Advertisement

Loading...

Rocket Doctor AI Inc.

AIDR.CNCNQ
Healthcare
Medical - Healthcare Information Services
$0.60
$-0.04(-6.25%)
Canadian Market opens in NaNh NaNm

Rocket Doctor AI Inc. Fundamental Analysis

Rocket Doctor AI Inc. (AIDR.CN) shows weak financial fundamentals with a PE ratio of -5.14, profit margin of -13.82%, and ROE of -1.90%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.36

Areas of Concern

ROE-1.90%
Operating Margin-13.95%
Cash Position0.32%
Current Ratio0.09
We analyze AIDR.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1508.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1508.9/100

We analyze AIDR.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

AIDR.CN struggles to generate sufficient returns from assets.

ROA > 10%
-38.22%

Valuation Score

Excellent

AIDR.CN trades at attractive valuation levels.

PE < 25
-5.14
PEG Ratio < 2
-0.36

Growth Score

Weak

AIDR.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

AIDR.CN shows balanced financial health with some risks.

Debt/Equity < 1
0.08
Current Ratio > 1
0.09

Profitability Score

Weak

AIDR.CN struggles to sustain strong margins.

ROE > 15%
-190.26%
Net Margin ≥ 15%
-13.82%
Positive Free Cash Flow
No

Key Financial Metrics

Is AIDR.CN Expensive or Cheap?

P/E Ratio

AIDR.CN trades at -5.14 times earnings. This suggests potential undervaluation.

-5.14

PEG Ratio

When adjusting for growth, AIDR.CN's PEG of -0.36 indicates potential undervaluation.

-0.36

Price to Book

The market values Rocket Doctor AI Inc. at 4.50 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.50

EV/EBITDA

Enterprise value stands at -7.14 times EBITDA. This is generally considered low.

-7.14

How Well Does AIDR.CN Make Money?

Net Profit Margin

For every $100 in sales, Rocket Doctor AI Inc. keeps $-13.82 as profit after all expenses.

-13.82%

Operating Margin

Core operations generate -13.95 in profit for every $100 in revenue, before interest and taxes.

-13.95%

ROE

Management delivers $-1.90 in profit for every $100 of shareholder equity.

-1.90%

ROA

Rocket Doctor AI Inc. generates $-38.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

-38.22%

Following the Money - Real Cash Generation

Operating Cash Flow

Rocket Doctor AI Inc. generates limited operating cash flow of $-5.32M, signaling weaker underlying cash strength.

$-5.32M

Free Cash Flow

Rocket Doctor AI Inc. generates weak or negative free cash flow of $-5.32M, restricting financial flexibility.

$-5.32M

FCF Per Share

Each share generates $-0.06 in free cash annually.

$-0.06

FCF Yield

AIDR.CN converts -7.45% of its market value into free cash.

-7.45%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.14

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.36

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.50

vs 25 benchmark

P/S Ratio

Price to sales ratio

99.43

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.08

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.09

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.90

vs 25 benchmark

ROA

Return on assets percentage

-0.38

vs 25 benchmark

ROCE

Return on capital employed

-0.62

vs 25 benchmark

How AIDR.CN Stacks Against Its Sector Peers

MetricAIDR.CN ValueSector AveragePerformance
P/E Ratio-5.1428.31 Better (Cheaper)
ROE-190.26%699.00% Weak
Net Margin-1381.98%-130884.00% (disorted) Weak
Debt/Equity0.080.34 Strong (Low Leverage)
Current Ratio0.092775.16 Weak Liquidity
ROA-38.22%-14469.00% (disorted) Weak

AIDR.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Rocket Doctor AI Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ